What are the risk factors and effectiveness of prophylaxis for venous thromboembolism in COVID-19 patients?, CEBM

This study identified a paucity of evidence for both the risks factors of VTE and the effectiveness of prophylactic strategies to prevent VTE in COVID-19 patients. Potential risk factors which were identified for thrombolytic events include older age and higher levels of D-dimer, though the actual threshold for a high level D-dimer varied between studies. Commonly encountered prophylactic strategies which were; low molecular weight heparin (LMWH) or unfractionned heparin, nadroparin and enoxaparin. A number of studies found that despite prophylaxis there was still a high incidence of thrombolytic complications in COVID-19 patients, which led a number of reviews to suggest earlier prophylaxis and in higher doses.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news